Skip to content
Home/Companies/Biotech/Quell Therapeutics
Quell Therapeutics

Quell Therapeutics

Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Quell Therapeutics?

Quell Therapeutics is currently owned by Jeito Capital through Jeito I (2021 vintage), since 2021. Across its history, Quell Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-13

Jeito Capital
Most recent investor
Jeito Capital
Jeito I · 2021 · VC
2 ownership periods · full history below

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by SV Health Managers and Jeito Capital since 2021.
Co-invest · 2 holders · 2021 · present
SV Health Managers
2021 · present(5yr) · SV7 Impact Medicine Fund · 2019 · Life Sciences VC
Jeito Capital
2021 · present(5yr) · Jeito I · 2021 · VC
Track Quell Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Quell Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Quell Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue